Hyperglycosylated hCG, a review

Placenta

Volumn 31, Issue 8, 2010, Pages 653-664

  Cole, L A ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Choriocarcinoma; Cytotrophoblast; Evolution; Extravillous cytotrophoblast; Gestational trophoblastic disease; Hemochorial placentation; Hyperglycosylated hCG; Hyperglycosylation; Implantation; Placenta; Spontaneous abortion

Indexed keywords

CHORIONIC GONADOTROPIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; GLYCOPROTEIN; HYPERGLYCOSYLATED CHORIONIC GONADOTROPIN; METHOTREXATE; UNCLASSIFIED DRUG;

ABDOMINAL HYSTERECTOMY; CHEMOTHERAPY; CHORIOCARCINOMA; CYTOTROPHOBLAST; DOWN SYNDROME; ECTOPIC PREGNANCY; GESTATIONAL AGE; GLYCOSYLATION; HUMAN; HYDATIDIFORM MOLE; MATERNAL HYPERTENSION; NONHUMAN; PREGNANCY; PREGNANCY TEST; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SPONTANEOUS ABORTION; SYNCYTIOTROPHOBLAST; TROPHOBLASTIC DISEASE;

EID: 77955980851     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2010.06.005     Document Type: Article

References (71)

1. Rao CV. Paradigm shift on the targets of hCG actions. In: Cole LA, editor. Human chorionic gonadotropin. Oxford: Elsevier, in press.
2. Rao CV. An overview of the past, present and future of nongonadal LH/hCG actions in reproductive biology and medicine.. Sem Reprod Endocrinol 2001;19:7-17.
3. Reshef E, Lei ZM, Rao CV, Pridham DD, Chegini N, Luborsky JL. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol Metab 1990;70:421-30.
4. Cole LA, Dai D, Butler SA, Leslie KK, Kohorn EI. Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG-regulated neoplasia. Gynecol Oncol 2006;102:144-9.
5. Cole LA, Khanlian SA, Riley JM, Butler SA. Hyperglycosylated hCG in gestational implantation and in choriocarcinoma and testicular germ cell malignancy tumorigenesis. J Reprod Med 2006;51:919-29.
6. Butler SA, Iles RK. Biological function of the free beta subunit: expression and treatment target in cancer. In: Cole LA, editor. Human chorionic gonadotropin. Oxford UK: Elsevier, in press.
7. Gillott DJ, Iles RK, Chard T. The effects of β-human chorionic gonadotropin on the in vitro growth of bladder cancer cell lines. Br J Cancer 1996;73:323-6.
8. Acevedo HF, Hartstock RJ. Metastatic phenotype correlates with high expression of membrane-associated complete β-human chorionic gonadotropin in vivo. Cancer 1996;78:2388-99.
9. Mizuochi T, Nishimura R, Derappe C, Taniguchi T, Hamamoto T, Mochizuki M, et al. Structures of the asparagine-linked sugar chains of human chorionic gonadotropin produced in choriocarcinoma. Appearance of triantennary sugar chains and unique biantennary sugar chains. J Biol Chem 1983;258:14126-9.
10. Cole LA, Birken S, Perini F. The structures of the serine-linked sugar chains on human chorionic gonadotropin. Biochem Biophys Res Comm 1985;126:333-9.
11. Cole LA. The O-linked oligosaccharides are strikingly different on pregnancy and choriocarcinoma hCG. J Clin Endocrinol Metab 1987;65:811-3.
12. Valmu L, Alfthan H, Hotakainen K, Birken S, Stenman UH. Site-specific glycan analysis of human chorionic gonadotropin β-subunit from malignancies and pregnancy by liquid chromatography - electrospray mass spectrometry. Glycobiol 2006;16:1207-18.
13. Elliott MM, Kardana A, Lustbader JW, Cole LA. Carbohydrate and peptide structure of the alpha- and beta-subunits of human chorionic gonadotropin from normaland aberrantpregnancy and choriocarcinoma. Endocrine 1997;7:15-32.
14. Kobata A, Takeuchi M. Structure, pathology and function of the N-linked sugar chains of human chorionic gonadotropin. Biochim Biophy Acta 1990;1455:315-26.
15. Birken S, Krichevsky A, O'Connor J, Schlatterer J, Cole L, Kardana A, et al. Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient: generation of antibodies that differentiate between pregnancy hCG and choriocarcinoma hCG. Endocrine 1999;10:137-44.
16. Cole LA, Shahabi S, Oz UA, Bahado-Singh RO, Mahoney MJ. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: a new basis for gestational Down syndrome screening. Clin Chem 1999;45:2109-19.
17. O'Connor J, Ellish N, Kakuma T, Shlatterer J, Kovalevskaya G. Differential urinary gonadotropin profiles in early pregnancy and early pregnancy loss. Prenat Diagn 1999;18:1232-40.
18. Sasaki Y, Ladner DG, Cole LA. Hyperglycosylated human chorionic gonadotropin and the source of pregnancy failure. Fert Steril 2008;89:1781-6.
19. Cole LA, Khanlian SA, Sutton JM, Davies S, Stephens N. Hyperglycosylated hCG (Invasive trophoblast antigen, ITA) a Key antigen for early pregnancy detection. Clin Biochem 2003;36:647-55.
20. Cole LA, Muller Y. hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases. Gyn Oncol 2010;116:3-9.
21. Kovalevskaya G, Genbacev O, Fisher SJ, Caceres E, O'Connor JF. Trophoblast origin of hCG isoforms: Cytotrophoblasts are the primary source of choriocarcinoma hCG. Mol Cell Endocrinol 2002;194:147-55.
22. Handshuh K, Guibourdenche J, Tsatsaris V, Guesnon M, Laurendeau I, Evain-Brion D, et al. Human chorionic gonadotropin produced by the invasive trophoblast but not the villous trophoblast promotes cell invasion and is down-regulated by peroxisome proliferator-activated receptor-a. Endocrinology 2007;148:5011-9.
23. Cole LA. hCG and hyperglycosylated hCG in the establishment and evolution of hemochorial placentation. J Reprod Immunol 2009;82:112-8.
24. Hamade AL, Nakabayashi K, Sato A, Kiyoshi K, Takamatsu Y, Laoag-Fernandez JB, et al. Transfection of antisense chorionic gonadotropin β gene into choriocarcinoma cells suppresses the cell proliferation and induces apoptosis. J Clin Endocrinol Metab 2005;90:4873-9.
25. Lei ZM, Taylor DD, Gercel-Taylor C, Rao CV. Human chorionic gonadotropin promotes tumorigenesis of choriocarcinoma JAR cells. Troph Res 1999;13:147-59.
26. Lapthorn AJ, Harris DC, Littlejohn A, Lustbader JW, Canfield RE, Machin KJ, et al. Crystal structure of human chorionic gonadotropin. Nature 1994;369:455-61.
27. Cole LA, Kardana A, Andrade-Gordon P, Gawinowicz MA, Morris JC, Bergert ER, et al. The heterogeneity of hCG: III. The occurrence, biological and immunological activities of nicked hCG. Endocrinology 1991;129:1559-67.
28. Khoo NK, Bechberger JF, Shepherd T, Bond SL, McCrae KR, Hamilton GS, et al. SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype I Mechanisms responsible for hyperinvasiveness and resistance to anti-invasive action of TGFβ. Intl J Cancer 1998;77:429-39.
29. Butler SA, Ikram MS, Mathieu S, Iles RK. The increase in bladder carcinoma cell population induced by the free beta subunit of hCG is a result of an antiapoptosis effect and not cell proliferation. Brit J Cancer 2000;82:1553-6.
30. Schuster N, Krieglstein K. Mechanisms of TGF-β-mediated apoptosis. Cell Tissue Res 2002;307:1-14.
31. Knittel T, Mehde M, Kobold D, Saile B, Dinter C, Ramadori G. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver regulation by TNF-alpha and TGF-beta1. J Hepatol 1999;30:48-60.
32. Norwitz ER, Schust DJ, Fisher SJ. Implantation and the survival of early pregnancy. N Engl J Med 2001;345:1400-8.
33. Jauniaux E, Poston L, Burton GJ. Placenta-related disease of pregnancy: involvement of oxidative stress and implications in human evolution. Hum Reprod Update 2006;12:747-56.
34. Cole LA, Shahabi S, Oz UA, Bahado-Singh RO, Mahoney MJ. Hyperglycosylated hCG (invasive trophoblast antigen) immunoassay: a new basis for gestational Down syndrome screening. Clin Chem 1999;45:2109-19.
35. Kelly LS, Birken S, Puett D. Determination of hyperglycosylated human chorionic gonadotropin produced by malignant gestational trophoblastic neoplasias and male germ cell tumors using a lectin-based immunoassay and surface plasmon resonance. Mol Cell Endocrinol 2007;260:33-9.
36. Spencer K, Talbot JA, Abushoufa RA. Maternal serum hyperglycosylated human chorionic gonadotrophin (HhCG) in the first trimester of pregnancies affected by Down syndrome, using a sialic acid-specific lectin immunoassay. Prenat Diagn 2002;22:656-62.
37. Talbot JA, Spencer K, Abushoufa RA. Detection of maternal serum glycoform variants in the secont trimester of pregnancies affected by Down syndrome using a lectin immunoassay. Prenat Diagn 2002;23:1-5.
38. Cole LA, Sutton JM, Higgins TN. Higgins, Cembrowski GS. Between-method variation in hCG test results. Clin Chem 2004;50:874-82.
39. Cole LA. Over-the-counter pregancy tests. In: Cole LA, editor. Human chorionic gonadotropin. Oxford UK: Elsevier, in press.
40. Cole LA. Human chorionic gonadotropin and associated molecules. Expert Rev Molec Diag 2009;9:51-73.
41. Muller CY, Cole LA. The quagmire of hCG and hCG testing in gynecologic oncology. Gynecol Oncol 2009;112:663-72.
42. Cole LA. Use of hCG tests for evaluating trophoblastic diseases: choosing an appropriate hCG assay, false detection of hCG, unexplained elevated hCG, and quiescent trophoblastic disease. In: Hancock BW, Newland ES, Berkowitz RS, Cole LA, editors. Gestational trophoblastic disease. 2nd ed., London: Chapman and Hall; 2002. p. 130-42.
43. Cole LA, Butler SA, Khanlian SA, Giddings A, Muller CY, Seckl MJ, et al. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia. Gynecol Oncol 2006;102:150-8.
44. Cole LA, Butler SA. Hyperglycosylated hCG and its free β-subunit, tumor markers and tumor promoters: a review. J Reprod Med 2008;53:499-510.
45. Hancock BW, Tidy JA. Clinical management of persistent low-level hCG elevation. Trophobl Dis Upd 2003;4:5-6.
46. Kohorn EI. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.. Gynecol Oncol 2002;85:315-20.
47. Goto S, Ino K, Mitsui T, Kikkawa F, Suzuki T, Nomura S, et al. Survival rates of patients with choriocarcinoma treated with chemotherapy without hysterectomy: effects of anticancer agents on subsequent births. Gynecol Oncol 2004;93:529-35.
48. Turan T, Karacay O, Tulunay G, Boran N, Koc S, Bozok S, et al. Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia. Intl J Gynecol Oncol 2006;16:1432-8.
49. Frendo JL, Vidaud M, Guibourdenche J, Luton D, Muller F, Bellet D, et al. Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down's syndrome. J Clin Edocrinol Metab 2000;85:3700-7.
50. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987;7:623-30.
51. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Canick JA, Haddow JE, et al. Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome. Br J Obstet Gynaecol 1988;95:334-41.
52. Wald NJ, Densem JW, Muttukvishna S, Knight PG. Prenatal screening for Down syndrome using inhibin A as a serum marker. Prenat Diagn 1996;16:143-53.
53. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in the first trimester of pregnancy. Br Med J 1992;304:867-89.
54. Palomaki GE, Knight GJ, Roberson MM, Cunningham GC, Lee JE, Strom CM, et al. Invasive trophoblast antigen (hyperglycosylated human chorionic gonadotropin) in second-trimester maternal urine as a marker for Down syndrome: preliminary results of an observational study on fresh samples. Clin Chem 2003;50:182-9.
55. Palomaki GE, Knight GJ, Neveux LM, Pandian R, Haddow JE. Maternal serum invasive trophoblast antigen and first-trimester Down syndrome screening. Clin Chem 2005;51:1499-504.
56. Bahado-Singh RO, Oz AU, Kingston JM, Shahabi S, Hsu CD, Cole LA. The role of hyperglycosylated hCG in trophoblast invasion and the prediction of subsequent preeclampsia. Prenat Diagn 2002;22:478-83.
57. Bjercke S, Tanbo T, Dale PO, Mørkrid L, Åbyholm T. Human chorionic gonadotropin concentrations in early pregnancy after in-vitro fertilization. Hum Reprod 1999;14:1642-6.
58. O'Connor J, Ellish N, Kakuma T, Shlatterer J, Kovalevskaya G. Differential urinary gonadotropin profiles in early pregnancy and early pregnancy loss. Prenat Diagn 1999;18:1232-40.
59. Kovalevskaya G, Birken S, Kakuma T, Ozaki N, Sauer M, Lindheim S, et al. Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope. J Endocrinol 2002;172:497-506.
60. Sutton-Riley JM, Khanlian SA, Byrn FW, Cole LA. A single serum test for measuring early pregnancy outcome with high predictive value. Clin Biochem 2006;39:682-7.
61. Cole LA, Khanlian SA, Kohorn EI. Evolution of the human brain, chorionic gonadotropin and hemochorial implantation of the placenta: insights into origins of pregnancy failures, preeclampsia and choriocarcinoma. J Reprod Med 2008;53:449-557.
62. Cole LA. hCG and hyperglycosylated hCG in the establishment and evolution of hemochorial placentation. J Reprod Immunol 2009;82:111-7.
63. Fiddes JC, Godman HM. The cDNA of the ß-subunit of human chorionic gonadotropin suggests evolution of a gene by readthrough into the 3' untranslated region. Nature 1979;281:351-6.
64. Maston GA, Ruvolo M. Chorionic gonadotropin has a recent origin within primates and an evolutionary history of selection. Molec Biol Evol 2002;19:320-35.
65. Gibbons A. Solving the brain's energy crisis. Science 1998;280:1345-7.
66. Martin RD. Scaling of the mammalian barrier: the maternal energy hypothesis. News Physiol Sci 1996;4:149-54.
67. Cunnane SC, Herbige LS, Crawford MA. The importance of energy and nutrient supply in human brain evolution. Nutr Health 1993;9:19-35.
68. Martin RD. Relative brain size and basal metabolic rate in terrestrial vertebrates. Nature 1981;293:57-60.
69. Norwitz ER, Schust DJ, Fisher SJ. Implantation and the survival of early pregnancy. New Engl J Med 2001;345:1400-8.
70. Jauniaux E, Poston L, Burton GJ. Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Hum Reprod Updt 2006;12:747-55.
71. Robillard PY, Hulset TC, Deka CG. Preeclampsia and human reproduction. An essay of a long term reflection. J Reprod Immunol 2003;59:93-100.